205 related articles for article (PubMed ID: 8383976)
21. E2F1-mediated human POMC expression in ectopic Cushing's syndrome.
Araki T; Liu NA; Tone Y; Cuevas-Ramos D; Heltsley R; Tone M; Melmed S
Endocr Relat Cancer; 2016 Nov; 23(11):857-870. PubMed ID: 27935805
[TBL] [Abstract][Full Text] [Related]
22. Loss of ACTH expression in cultured human corticotroph macroadenoma cells is consistent with loss of the POMC gene signal sequence.
Rees DA; Hepburn PJ; McNicol AM; Francis K; Jasani B; Lewis MD; Farrell WE; Lewis BM; Scanlon MF; Ham J
Mol Cell Endocrinol; 2002 Mar; 189(1-2):51-7. PubMed ID: 12039064
[TBL] [Abstract][Full Text] [Related]
23. A pituitary tumor producing high molecular weight adrenocorticotropin-related peptides: clinical and cell culture studies.
Fuller PJ; Lim AT; Barlow JW; White EL; Khalid BA; Copolov DL; Lolait S; Funder JW; Stockigt JR
J Clin Endocrinol Metab; 1984 Jan; 58(1):134-42. PubMed ID: 6315755
[TBL] [Abstract][Full Text] [Related]
24. Role of NeuroD1 on the negative regulation of Pomc expression by glucocorticoid.
Parvin R; Saito-Hakoda A; Shimada H; Shimizu K; Noro E; Iwasaki Y; Fujiwara K; Yokoyama A; Sugawara A
PLoS One; 2017; 12(4):e0175435. PubMed ID: 28406939
[TBL] [Abstract][Full Text] [Related]
25. Low level of glucocorticoid receptor messenger ribonucleic acid in pituitary adenomas manifesting Cushing's disease with resistance to a high dose-dexamethasone suppression test.
Mu YM; Takayanagi R; Imasaki K; Ohe K; Ikuyama S; Yanase T; Nawata H
Clin Endocrinol (Oxf); 1998 Sep; 49(3):301-6. PubMed ID: 9861319
[TBL] [Abstract][Full Text] [Related]
26. β-arrestin expression in corticotroph tumor cells is modulated by glucocorticoids.
Gatto F; Feelders RA; van der Pas R; van Koetsveld P; Bruzzone E; Arvigo M; Dogan F; Lamberts S; Ferone D; Hofland L
J Endocrinol; 2020 Apr; 245(1):101-113. PubMed ID: 32027601
[TBL] [Abstract][Full Text] [Related]
27. Unrestrained production of proopiomelanocortin (POMC) and its peptide fragments by pituitary corticotroph adenomas in Cushing's disease.
Bertagna X
J Steroid Biochem Mol Biol; 1992 Oct; 43(5):379-84. PubMed ID: 1327071
[TBL] [Abstract][Full Text] [Related]
28. The expression of glucocorticoid and mineralocorticoid receptors in pituitary tumors causing Cushing's disease and silent corticotroph tumors.
Kober P; Rusetska N; Mossakowska BJ; Maksymowicz M; Pękul M; Zieliński G; Styk A; Kunicki J; Działach Ł; Witek P; Bujko M
Front Endocrinol (Lausanne); 2023; 14():1124646. PubMed ID: 37065760
[TBL] [Abstract][Full Text] [Related]
29. Neuromedin B receptor as a potential therapeutic target for corticotroph adenomas.
Sekizaki T; Kameda H; Nakamura A; Kuwabara S; Nomoto H; Cho KY; Ishi Y; Motegi H; Miyoshi H; Atsumi T
Pituitary; 2023 Oct; 26(5):597-610. PubMed ID: 37642928
[TBL] [Abstract][Full Text] [Related]
30. Effects of tubastatin A on adrenocorticotropic hormone synthesis and proliferation of AtT-20 corticotroph tumor cells.
Hagiwara R; Kageyama K; Iwasaki Y; Niioka K; Daimon M
Endocr J; 2022 Sep; 69(9):1053-1060. PubMed ID: 35296577
[TBL] [Abstract][Full Text] [Related]
31. The cellular and molecular basis of the ectopic ACTH syndrome.
White A; Clark AJ
Clin Endocrinol (Oxf); 1993 Aug; 39(2):131-41. PubMed ID: 8396510
[TBL] [Abstract][Full Text] [Related]
32. Analysis of co-factor function in a glucocorticoid-resistant small cell carcinoma cell line.
Waters CE; Stevens A; White A; Ray DW
J Endocrinol; 2004 Nov; 183(2):375-83. PubMed ID: 15531725
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of heat shock protein 90 decreases ACTH production and cell proliferation in AtT-20 cells.
Sugiyama A; Kageyama K; Murasawa S; Ishigame N; Niioka K; Daimon M
Pituitary; 2015 Aug; 18(4):542-53. PubMed ID: 25280813
[TBL] [Abstract][Full Text] [Related]
34. Biochemical assessment of Cushing's disease in patients with corticotroph macroadenomas.
Katznelson L; Bogan JS; Trob JR; Schoenfeld DA; Hedley-Whyte ET; Hsu DW; Zervas NT; Swearingen B; Sleeper M; Klibanski A
J Clin Endocrinol Metab; 1998 May; 83(5):1619-23. PubMed ID: 9589666
[TBL] [Abstract][Full Text] [Related]
35. The multi-ligand somatostatin analogue SOM230 inhibits ACTH secretion by cultured human corticotroph adenomas via somatostatin receptor type 5.
Hofland LJ; van der Hoek J; Feelders R; van Aken MO; van Koetsveld PM; Waaijers M; Sprij-Mooij D; Bruns C; Weckbecker G; de Herder WW; Beckers A; Lamberts SW
Eur J Endocrinol; 2005 Apr; 152(4):645-54. PubMed ID: 15817922
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of vasopressin (V3) and corticotrophin-releasing hormone receptor genes in corticotroph tumours.
de Keyzer Y; René P; Beldjord C; Lenne F; Bertagna X
Clin Endocrinol (Oxf); 1998 Oct; 49(4):475-82. PubMed ID: 9876345
[TBL] [Abstract][Full Text] [Related]
37. Silibinin, an HSP90 Inhibitor, on Human ACTH-Secreting Adenomas.
Pecori Giraldi F; Cassarino MF; Sesta A; Lasio G; Losa M
Neuroendocrinology; 2023; 113(6):606-614. PubMed ID: 36791678
[TBL] [Abstract][Full Text] [Related]
38. Inhibitory effect of prepro-thyrotrophin-releasing hormone (178-199) on adrenocorticotrophic hormone secretion by human corticotroph tumours.
Pecori Giraldi F; Pesce S; Maroni P; Pagliardini L; Lasio G; Losa M; Cavagnini F
J Neuroendocrinol; 2010 Apr; 22(4):294-300. PubMed ID: 20136686
[TBL] [Abstract][Full Text] [Related]
39. The Effects of Smad3 on Adrenocorticotropic Hormone-Secreting Pituitary Adenoma Development, Cell Proliferation, Apoptosis, and Hormone Secretion.
Zhou YZ; Li CZ; Gao H; Zhang YZ
World Neurosurg; 2018 Jun; 114():e329-e337. PubMed ID: 29524699
[TBL] [Abstract][Full Text] [Related]
40. Why don't corticotroph tumors always produce Cushing's disease?
García-Martínez A; Cano DA; Flores-Martínez A; Gil J; Puig-Domingo M; Webb SM; Soto-Moreno A; Picó A
Eur J Endocrinol; 2019 Sep; 181(3):351-361. PubMed ID: 31319379
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
